Daan Gene Co., Ltd. — Investor Relations & Filings
Filings indexed
2,189
across all filing types
Latest filing
2025-10-30
Regulatory Filings
Country
CN
China
Listing
Shenzhen Stock Exchange
002030
Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会薪酬与考核委员会工作细则（2025年10月） | 2025-10-30 | Chinese | |
| 对外担保管理制度（2025年10月） | 2025-10-30 | Chinese | |
| 年报信息披露重大差错责任追究制度（2025年10月） | 2025-10-30 | Chinese | |
| 内幕信息知情人登记管理制度（2025年10月） | 2025-10-30 | Chinese | |
| 关于授权出售公司所持部分股票资产的公告 | 2025-10-30 | Chinese | |
| 关于2025年前三季度计提资产减值准备的公告 | 2025-10-30 | Chinese |
Browse filings by year
23 years- 2026 38 filings
- 2025 128 filings
- 2024 93 filings
- 2023 73 filings
- 2022 157 filings
- 2021 134 filings
- 2020 120 filings
- 2019 94 filings
- 2018 116 filings
- 2017 110 filings
- 2016 132 filings
- 2015 172 filings
- 2014 167 filings
- 2013 95 filings
- 2012 64 filings
- 2011 57 filings
- 2010 72 filings
- 2009 66 filings
- 2008 63 filings
- 2007 84 filings
- 2006 55 filings
- 2005 78 filings
- 2004 21 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44391415 | 董事会薪酬与考核委员会工作细则（2025年10月） | 2025-10-30 | Chinese | ||
| 44391403 | 对外担保管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391392 | 年报信息披露重大差错责任追究制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391382 | 内幕信息知情人登记管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391362 | 关于授权出售公司所持部分股票资产的公告 | 2025-10-30 | Chinese | ||
| 44391345 | 关于2025年前三季度计提资产减值准备的公告 | 2025-10-30 | Chinese | ||
| 44391331 | 董事会秘书工作制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391316 | 对外提供财务资助管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391300 | 证券投资管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391287 | 对外投资管理办法（2025年10月） | 2025-10-30 | Chinese | ||
| 44391270 | 信息披露管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391259 | 投资者关系管理制度（2025年10月） | 2025-10-30 | Chinese | ||
| 44391240 | 上市公司独立董事候选人声明与承诺（刘焕亮） | 2025-10-30 | Chinese | ||
| 44391224 | 第九届董事会2025年第三次临时会议决议公告 | 2025-10-30 | Chinese | ||
| 44391212 | 董事会战略委员会工作细则（2025年10月） | 2025-10-30 | Chinese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Daan Gene Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54093/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54093 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54093 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54093 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54093}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Daan Gene Co., Ltd. (id: 54093)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.